The wikipedia page explicitely states that they don’t have the same binding profile and also Ockham’s razor as it seems unlikely that two different drugs with two different binding profile perform similarly on ADHD.
“stronger per weight impact on dopamine”? That’s not how drugs or biology work. Every neurotransmitter and hormone has several different receptors that different drugs affect in different ways.
I’m aware. I know my sentence did not sound professional but it was on purpose. I think it’s true nonetheless : using a more specific sentence would involve naming specific receptors and I don’t want to check each of them (MPH, ETH, modafinil). Being specific here doesn’t really matter because I’m expressing surprise as to your apparent certainty. Your certainty indicates that you researched those specifics, hence what I was asking.
Regarding the study you linked, I don’t find anything relevant to ETH’s effectiveness compared to MPH on ADHD.
To clarify because I think I sound rash when really I’m not:
I’m surprised you seem to have low uncertainty on ETH being more effective than MPH on ADHD, even though ETH has never been studied on ADHD, never been compared to MPH, possibly never even been studied on humans (?).
It is certain that ETH and MPH don’t have the same binding profile. I would be extremely surprised if they didn’t have a difference in effectiveness in treating ADHD if compared in a head to head RCT. But I don’t really have an opinion on which would be better. You seem to do so I’m probably lacking information about some neurotransmitters and ADHD.
PS: actually I do think ETH would perform worse than MPH. But probably not by a large margin. ETH could also be more pleasurable but less tolerable. All of this with very low certainty.
The wikipedia page explicitely states that they don’t have the same binding profile and also Ockham’s razor as it seems unlikely that two different drugs with two different binding profile perform similarly on ADHD.
I’m aware. I know my sentence did not sound professional but it was on purpose. I think it’s true nonetheless : using a more specific sentence would involve naming specific receptors and I don’t want to check each of them (MPH, ETH, modafinil). Being specific here doesn’t really matter because I’m expressing surprise as to your apparent certainty. Your certainty indicates that you researched those specifics, hence what I was asking.
Regarding the study you linked, I don’t find anything relevant to ETH’s effectiveness compared to MPH on ADHD.
To clarify because I think I sound rash when really I’m not:
I’m surprised you seem to have low uncertainty on ETH being more effective than MPH on ADHD, even though ETH has never been studied on ADHD, never been compared to MPH, possibly never even been studied on humans (?).
It is certain that ETH and MPH don’t have the same binding profile. I would be extremely surprised if they didn’t have a difference in effectiveness in treating ADHD if compared in a head to head RCT. But I don’t really have an opinion on which would be better. You seem to do so I’m probably lacking information about some neurotransmitters and ADHD.
PS: actually I do think ETH would perform worse than MPH. But probably not by a large margin. ETH could also be more pleasurable but less tolerable. All of this with very low certainty.